Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey (vol 23, pg 510, 2004)

被引：1

作者：

Baysallar, M ^{[1
]}

Kilic, A

Aydogan, H

Cilli, F

Doganci, L

机构：

[1] Gulhane Mil Med Acad, Dept Microbiol & Clin Microbiol, TR-06018 Ankara, Turkey

[2] Ege Univ, Fac Med, Dept Microbiol & Clin Microbiol, Izmir, Turkey

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2005年 / 25卷 / 01期

关键词：

D O I：

10.1016/j.ijantimicag.2004.10.006

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：93 / 93

页数：1

共 50 条

[21] Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare
Calfee, David P.
CURRENT OPINION IN INFECTIOUS DISEASES, 2012, 25 (04) : 385 - 394
[22] Quinupristin/dalfopristin and linezolid have important roles in the treatment of infections due to vancomycin-resistant enterococci
不详
Drugs & Therapy Perspectives, 2002, 18 (9) : 14 - 17
[23] Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in rural communities, western United States
Stevenson, KB
Searle, K
Stoddard, GJ
Samore, MH
EMERGING INFECTIOUS DISEASES, 2005, 11 (06) : 895 - 903
[24] Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci:: Emerging problems and new prospects for management
Noskin, GA
ANNALS ACADEMY OF MEDICINE SINGAPORE, 2001, 30 (03) : 320 - 331
[25] Predicting Clearance of Colonization with Vancomycin-Resistant Enterococci and Methicillin-Resistant Staphylococcus aureus by Use of Weekly Surveillance Cultures
Huckabee, Charmaine M.
Huskins, W. Charles
Murray, Patrick R.
JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (04) : 1229 - 1230
[26] Susceptibility of vancomycin resistant enterococci, methicillin resistant Staphylococcus aureus and vancomycin intermediate staphylococci to linezolid
Garganera, DAC
Carey, R
O'Keefe, JP
CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1179 - 1179
[27] Antimicrobial therapy of multidrug-resistant Streptococcus pneumoniae, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus
Cunha, Burke A.
MEDICAL CLINICS OF NORTH AMERICA, 2006, 90 (06) : 1165 - +
[28] An Evaluation of the Prevalence of Vancomycin-Resistant Enterococci (VRE) and Methicillin-Resistant Staphylococcus aureus (MRSA) in Hospital Food
Kwon, Jennie H.
Reske, Kimberly A.
Hink, Tiffany
Seiler, Sondra M.
Wallace, Meghan A.
Bommarito, Kerry M.
Burnham, Carey-Ann D.
Dubberke, Erik R.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2017, 38 (11): : 1373 - 1375
[29] Epidemiology of infection and colonization with vancomycin-resistant enterococci and frequency of cocolonization with methicillin-resistant Staphylococcus aureus in children
Benson, Lacey
Sprague, Bruce
Campos, Joseph
Singh, Nalini
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (07): : 880 - 882
[30] Linezolid versus vancomycin for methicillin-resistant Staphylococcus aureus infections
Johnson, JR
CLINICAL INFECTIOUS DISEASES, 2003, 36 (02) : 236 - 237

← 1 2 3 4 5 →